BioCentury
ARTICLE | Clinical News

SYN-010: Extension study data

January 25, 2016 8:00 AM UTC

Top-line data from 54 breath methane-positive IBS-C patients in the open-label extension of the double-blind, placebo-controlled, U.S. Phase II SB-2-010-001 trial showed that once-daily 42 mg oral SYN...